George Monks, Ryan Rivera-Oyola, Mark Lebwohl. J Clin Aesthet Dermatol 2021
Times Cited: 1
Times Cited: 1
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.
Jason E Hawkes, Bernice Y Yan, Tom C Chan, James G Krueger. J Immunol 2018
Jason E Hawkes, Bernice Y Yan, Tom C Chan, James G Krueger. J Immunol 2018
100
100
Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F.
Ralph Adams, Asher Maroof, Terry Baker, Alastair D G Lawson, Ruth Oliver, Ross Paveley, Steve Rapecki, Stevan Shaw, Pavan Vajjah, Shauna West,[...]. Front Immunol 2020
Ralph Adams, Asher Maroof, Terry Baker, Alastair D G Lawson, Ruth Oliver, Ross Paveley, Steve Rapecki, Stevan Shaw, Pavan Vajjah, Shauna West,[...]. Front Immunol 2020
100
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis.
Joel Reis, Ron Vender, Tiago Torres. BioDrugs 2019
Joel Reis, Ron Vender, Tiago Torres. BioDrugs 2019
100
First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis.
Sophie Glatt, Eric Helmer, Birgit Haier, Foteini Strimenopoulou, Graham Price, Pavan Vajjah, Olivier A Harari, John Lambert, Stevan Shaw. Br J Clin Pharmacol 2017
Sophie Glatt, Eric Helmer, Birgit Haier, Foteini Strimenopoulou, Graham Price, Pavan Vajjah, Olivier A Harari, John Lambert, Stevan Shaw. Br J Clin Pharmacol 2017
100
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial.
Kristian Reich, Kim A Papp, Andrew Blauvelt, Richard G Langley, April Armstrong, Richard B Warren, Kenneth B Gordon, Joseph F Merola, Yukari Okubo, Cynthia Madden,[...]. Lancet 2021
Kristian Reich, Kim A Papp, Andrew Blauvelt, Richard G Langley, April Armstrong, Richard B Warren, Kenneth B Gordon, Joseph F Merola, Yukari Okubo, Cynthia Madden,[...]. Lancet 2021
100
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.
Kenneth B Gordon, Peter Foley, James G Krueger, Andreas Pinter, Kristian Reich, Ronald Vender, Veerle Vanvoorden, Cynthia Madden, Katy White, Christopher Cioffi,[...]. Lancet 2021
Kenneth B Gordon, Peter Foley, James G Krueger, Andreas Pinter, Kristian Reich, Ronald Vender, Veerle Vanvoorden, Cynthia Madden, Katy White, Christopher Cioffi,[...]. Lancet 2021
100
Bimekizumab versus Secukinumab in Plaque Psoriasis.
Kristian Reich, Richard B Warren, Mark Lebwohl, Melinda Gooderham, Bruce Strober, Richard G Langley, Carle Paul, Dirk De Cuyper, Veerle Vanvoorden, Cynthia Madden,[...]. N Engl J Med 2021
Kristian Reich, Richard B Warren, Mark Lebwohl, Melinda Gooderham, Bruce Strober, Richard G Langley, Carle Paul, Dirk De Cuyper, Veerle Vanvoorden, Cynthia Madden,[...]. N Engl J Med 2021
100
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial.
Kim A Papp, Joseph F Merola, Alice B Gottlieb, Christopher E M Griffiths, Nancy Cross, Luke Peterson, Christopher Cioffi, Andrew Blauvelt. J Am Acad Dermatol 2018
Kim A Papp, Joseph F Merola, Alice B Gottlieb, Christopher E M Griffiths, Nancy Cross, Luke Peterson, Christopher Cioffi, Andrew Blauvelt. J Am Acad Dermatol 2018
100
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications.
Rohan Singh, Sindhuja Koppu, Patrick O Perche, Steven R Feldman. Int J Mol Sci 2021
Rohan Singh, Sindhuja Koppu, Patrick O Perche, Steven R Feldman. Int J Mol Sci 2021
100
Bimekizumab for the Treatment of Psoriasis.
Egídio Freitas, Andrew Blauvelt, Tiago Torres. Drugs 2021
Egídio Freitas, Andrew Blauvelt, Tiago Torres. Drugs 2021
100
Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.
Anna R Huppler, Shrinivas Bishu, Sarah L Gaffen. Arthritis Res Ther 2012
Anna R Huppler, Shrinivas Bishu, Sarah L Gaffen. Arthritis Res Ther 2012
100
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach. Cochrane Database Syst Rev 2022
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach. Cochrane Database Syst Rev 2022
100
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.
April W Armstrong, Charlotte Read. JAMA 2020
April W Armstrong, Charlotte Read. JAMA 2020
100
Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Fan Bai, Gang Gang Li, Qingmin Liu, Xinwu Niu, Ruilian Li, Huiqun Ma. J Immunol Res 2019
Fan Bai, Gang Gang Li, Qingmin Liu, Xinwu Niu, Ruilian Li, Huiqun Ma. J Immunol Res 2019
100
Bimekizumab versus Adalimumab in Plaque Psoriasis.
Richard B Warren, Andrew Blauvelt, Jerry Bagel, Kim A Papp, Paul Yamauchi, April Armstrong, Richard G Langley, Veerle Vanvoorden, Dirk De Cuyper, Christopher Cioffi,[...]. N Engl J Med 2021
Richard B Warren, Andrew Blauvelt, Jerry Bagel, Kim A Papp, Paul Yamauchi, April Armstrong, Richard G Langley, Veerle Vanvoorden, Dirk De Cuyper, Christopher Cioffi,[...]. N Engl J Med 2021
100
Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors.
Raishan S Bakar, Sharifah Z S Jaapar, Afiq F Azmi, Yeoh C Aun. J Taibah Univ Med Sci 2021
Raishan S Bakar, Sharifah Z S Jaapar, Afiq F Azmi, Yeoh C Aun. J Taibah Univ Med Sci 2021
100
Return-to-work, disabilities and occupational health in the age of COVID-19.
Diane Godeau, Audrey Petit, Isabelle Richard, Yves Roquelaure, Alexis Descatha. Scand J Work Environ Health 2021
Diane Godeau, Audrey Petit, Isabelle Richard, Yves Roquelaure, Alexis Descatha. Scand J Work Environ Health 2021
100
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules.
Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni. Biologics 2021
Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni. Biologics 2021
100
Psoriasis and Treatment: Past, Present and Future Aspects.
Claire Reid, Christopher E M Griffiths. Acta Derm Venereol 2020
Claire Reid, Christopher E M Griffiths. Acta Derm Venereol 2020
100
Bimekizumab: the new drug in the biologics armamentarium for psoriasis.
Egídio Freitas, Tiago Torres. Drugs Context 2021
Egídio Freitas, Tiago Torres. Drugs Context 2021
100
Psoriasis: a brief overview.
Antony Raharja, Satveer K Mahil, Jonathan N Barker. Clin Med (Lond) 2021
Antony Raharja, Satveer K Mahil, Jonathan N Barker. Clin Med (Lond) 2021
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.